investor.sppirx.com
Spectrum Pharmaceuticals, Inc. - Investor RelationsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
http://investor.sppirx.com/
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
http://investor.sppirx.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
0.5 seconds
16x16
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
8
SITE IP
206.200.251.19
LOAD TIME
0.481 sec
SCORE
6.2
Spectrum Pharmaceuticals, Inc. - Investor Relations | investor.sppirx.com Reviews
https://investor.sppirx.com
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
investor.sppirx.com
Spectrum Pharmaceuticals, Inc. - Press Releases
http://investor.sppirx.com/releases.cfm
Annual Report and Proxy Information. Spectrum Pharmaceuticals Provides Third Quarter Financial and Pipeline Update. Nov 3, 2016. Financial Update: Q3 revenues were $33.4 million, including $30.3 million in product sales, with recently launched drug EVOMELAÂ (melphalan) for injection contributing $5.9 million. The Company ended the quarter with Cash and Cash Equivalents of $171.9 million. Earnings Call Updat. Spectrum Pharmaceuticals Announces Third Quarter 2016 Financial Results Teleconference and Webcast.
Spectrum Pharmaceuticals, Inc. - Analyst Coverage
http://investor.sppirx.com/analysts.cfm
Annual Report and Proxy Information. FBR Capital Markets and Co. HC Wainwright and Co. Swayampakula Ramakanth, Ph.D. 4:00 PM ET on Nov 4, 2016. Delayed at least 20 minutes. Annual report and proxy information.
Spectrum Pharmaceuticals, Inc. - Stock Information
http://investor.sppirx.com/stockquote.cfm
Annual Report and Proxy Information. Spectrum Pharmaceuticals (NASDAQ: SPPI). 4:00 PM ET on Nov 4, 2016. Sign up for email alerts. Annual report and proxy information.
Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast (NASDAQ:SPPI)
http://investor.sppirx.com/releasedetail.cfm?ReleaseID=924691
Laquo; Previous Release. Next Release ». July 30, 2015. Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast. Thursday, August 6, 2015. Domestic: (877) 837-3910, Conference ID# 85787537. International: (973) 796-5077, Conference ID# 85787537. For interested individuals unable to join the call, a replay will be available from August 6, 2015 @ 7:30 pm ET/4:30 pm PT through August 19, 2015 until. Domestic Replay Dial-In #: (855) 859-2056, Conference ID# 85787537.
Spectrum Pharmaceuticals, Inc. - Investor Relations
http://investor.sppirx.com/index.cfm
Annual Report and Proxy Information. Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System. View all ». Aug 9, 2016. Spectrum Pharmaceuticals Reports Second Quarter 2016 Financial Results and Pipeline Update. Aug 2, 2016. Spectrum Pharmaceuticals Announces Second Quarter 2016 Financial Results Teleconference and Webcast. Jul 13, 2016. Spectrum Pharmaceuticals Settles FOLOTYN (pralatrexate injection) ANDA Patent Litigation. 4:00 PM ET on Aug 26, 2016. Delayed at least 20 minutes.
TOTAL PAGES IN THIS WEBSITE
20
SpareBank 1 Gruppen – Investor relasjoner – Investor Relations – IR - Investor relasjoner
Invitasjon: Resultatpresentasjon – 2. kvartal 2015. SpareBank 1 SMN, SpareBank 1 SR-Bank ASA, SpareBank 1 Nord-Norge, Sparebanken Hedmark og SpareBank 1 Gruppen inviterer til presentasjon av 2. kvartal 2015. Les mer →. God start på året for SpareBank 1 Gruppen. SpareBank 1 Gruppen leverer det nest beste første kvartalsresultatet noen sinne, med et resultat før skatt på MNOK 378 (337). Annualisert egenkapitalavkastning pr 31.03.15 endte på sterke 17,8 % (16,7). Les mer →. Her er årsrapporten for 2014.
������������������� ������������ �����-����������
Pap-For Russia - 2006. CeBIT 2005 10 16. CeBIT 2005 10 16. Wal-Mart, Aldi, Lidl Auchan .
Кабинет инвестора / Личный кабинет
Информационно-аналитический ресурс Кабинет инвестора. Аналитика и торговые идеи. Рынок создан специально для российского частного инвестора, торговые терминалы, тарифы и принципы совершения сделок такие же, как и при торговле на российском рынке. На нашем рынке сохранены все привычные для Вас условия торговли, к ним же прибавляются еще и достоинства американского рынка акций. Санкт-Петербургская биржа представляет Вашему вниманию ряд мероприятий, как очных, так и в формате вебинара, которые помогут Вам н...
Overview - Investor Relations - SPNC
Spectranetics at the Canaccord Genuity Growth Conference. 160;at 8:30 am ET. SPNC develops, manufactures, markets and distributes medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are sold in over 65 countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads. 08/12/15 8:30 am ET. Spectranetics at the Canaccord Genuity Growth Conference. 160; 0.35. Minimum 20 minute delay.
Investor Relations - S&P Global
Our Purpose and Values. SEC Filings and Reports. S&P Global Market Intelligence. S&P Dow Jones Indices. CRISIL, An S&P Global Company. Our Purpose and Values. SEC Filings and Reports. S&P Globals 4th Quarter and Full-Year 2016 Earnings Conference Call/Webcast on Tuesday, February 7, 2017. S&P Global 2016 Investor Fact Book. S&P Global to Present at the Goldman Sachs U.S. Financial Services Conference on December 7. Completed cost savings target of $140 million in 2016. Increase in adjusted diluted EPS.
Spectrum Pharmaceuticals, Inc. - Investor Relations
Annual Report and Proxy Information. Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System. View all ». Aug 6, 2015. Spectrum Pharmaceuticals Reports Second Quarter 2015 Financial Results and Pipeline Update. Jul 30, 2015. Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast. 4:00 PM ET on Aug 14, 2015. Delayed at least 20 minutes. Annual report and proxy information.
Star Petroleum Refining Public Company Limited
Management discussion and analysis. SPRC refinery site visit. Updated: 12 Jan 2017 16:37. Date: 14 Nov 2016.
Stock Quote | SPX Corporation
160; 0.40. 2,653,979,680. 08/07/15 4:00 pm ET. Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Minimum 20 minutes delayed.
SPY Inc. - Investor Relations Home
08/03/15 4:00 pm ET. Minimum 20 minute delay - Refresh quote. SPY Inc. designs, develops, produces and markets premium eyewear, apparel and accessories for the action sports, motorsports, snow sports, endurance sports and fashion-lifestyle markets. SPY Inc. Reports Financial Results for the First Quarter 2015. SPY Inc. Reports Financial Results for the Fourth Quarter 2014. Spy Inc. Reports Financial Results for the Third Quarter 2014. SPY Happily Reinvents Monochrome with its Whitewall Series.
SS&C Technologies, Inc. - Investors
Skip to main content. REIT Accounting and Administration. Performance Measurement and Attribution. Reconciliation and Data Collection. Products A to Z. Technology and Operations Outsourcing. Stock Quote and Chart. Annual Reports and Proxy. Headquartered in Windsor, Connecticut and with offices throughout North America, Europe, Asia, and Australia, SS&C (NASDAQ: SSNC) is a leading provider of services and software for the global financial services industry. SS&C To Acquire DST Systems. Opens in new window).
Investor Relations | Investor
Learn more about cookies. Image and Video Gallery. Environment, Health and Safety. Marketing and Our View on Smoking. Sign Up for Company Announcements. Sign up for News. About Scandinavian Tobacco Group. Scandinavian Tobacco Group A/S Annual Shareholder Meeting. First quarter interim report. Annual General Meeting 2016. Our Group is all about creating moments of great enjoyment for smokers. This promise has made us a world leading manufacturer of cigars and pipe tobacco. Brands in our product ranges.
SOCIAL ENGAGEMENT